Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ivermectin: effectiveness in lymphatic filariasis.

K R Brown1, F M Ricci, E A Ottesen

  • 1Merck Research Laboratories, Merck & Co., Inc., West Point, PA 19486, USA.

Parasitology
|June 2, 2001
PubMed
Summary

Ivermectin effectively clears microfilaraemia in lymphatic filariasis (LF) with single doses. Adverse events are due to inflammatory responses to dying parasites, not drug toxicity, making it a safe and vital tool for LF elimination.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reassigning the CaH<sup>+</sup> 1<sup>1</sup>Σ → 2<sup>1</sup>Σ vibronic transition with CaD<sup></sup>.

The Journal of chemical physics·2017
Same author

Endotypes of difficult-to-control asthma in inner-city African American children.

PloS one·2017
Same author

Acute exposure to ergot alkaloids from endophyte-infected tall fescue does not alter absorptive or barrier function of the isolated bovine ruminal epithelium.

Animal : an international journal of animal bioscience·2015
Same author

Tunable spin-spin interactions and entanglement of ions in separate potential wells.

Nature·2014
Same author

In-vacuum active electronics for microfabricated ion traps.

The Review of scientific instruments·2014
Same author

Antagonism of lateral saphenous vein serotonin receptors from steers grazing endophyte-free, wild-type, or novel endophyte-infected tall fescue.

Journal of animal science·2013

Area of Science:

  • Medical parasitology
  • Pharmacology
  • Public health

Background:

  • Lymphatic filariasis (LF) is a debilitating parasitic disease.
  • Current control programs rely on mass drug administration.
  • Ivermectin has shown promise in treating LF.

Purpose of the Study:

  • To review studies on ivermectin's efficacy and safety for LF.
  • To determine optimal dosing for microfilarial clearance.
  • To assess the safety profile of ivermectin in LF patients.

Main Methods:

  • Systematic review of published studies on ivermectin for LF.
  • Analysis of dose-response data for microfilarial clearance.
  • Evaluation of safety data and adverse event reporting.

Related Experiment Videos

Main Results:

  • Single-dose ivermectin (20-400 microg/kg) effectively clears microfilaraemia for Wuchereria bancrofti and Brugia malayi.
  • Higher doses (200-400 microg/kg) provide greater and more sustained reduction.
  • Adverse events are linked to host inflammatory responses, not drug toxicity.

Conclusions:

  • Ivermectin is a highly effective and well-tolerated microfilaricide for LF.
  • It is a potential key component for global LF elimination strategies.
  • Recommended doses of 200-400 microg/kg are suitable for LF control programs.